Yujin Jiang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Yujin Jiang

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Journal of Viral Hepatitis|December 23, 2022

Early clinical efficacy of pegylated interferon treatment in patients with different phases of chronic HBV infection: A real-world analysisWencong Zhang, Mingyou Xing, Wenjin Sun, et al.

BMC Infectious Diseases|October 14, 2021

Intestinal microbiota has important effect on severity of hand foot and mouth disease in childrenChenguang Shen, Yi Xu, Jingkai Ji, et al.

International Immunopharmacology|April 30, 2021

Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trialHong Zhao, Chi Zhang, Qi Zhu, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Journal of Viral Hepatitis|December 23, 2022

Early clinical efficacy of pegylated interferon treatment in patients with different phases of chronic HBV infection: A real-world analysisWencong Zhang, Mingyou Xing, Wenjin Sun, et al.

BMC Infectious Diseases|October 14, 2021

Intestinal microbiota has important effect on severity of hand foot and mouth disease in childrenChenguang Shen, Yi Xu, Jingkai Ji, et al.

International Immunopharmacology|April 30, 2021

Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trialHong Zhao, Chi Zhang, Qi Zhu, et al.

Pageof 2